Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications

Vafa Abilova, Amanj Kurdi, Brian Godman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: There have been a numerous initiatives in Azerbiajan in recent years to improve antibiotic utilization including educational programmes among patients, pharmacists and physicians. This study aimed to analyse the influence of these multiple initiatives on antibiotic utilization as a basis for suggesting future initiatives.

Methods: Observational retrospective study of total antibiotic utilization from 2011 to 2015 based on import data. The quality of aggregated antibiotic prescribing was assessed against recognised indicators including those of WHO Europe, as well as compared to neighbouring countries as reference points.

Results: There was a significant reduction in total antibiotic utilization from 17.1DIDs in 2011 in Azerbaijan to 8.02 DIDs in 2015, the lowest level compared with similar countries. Beta lactam antibiotics were typically the largest group of antibiotics with low overall use of co-amoxiclav (although relative utilisation rising), macrolides, cephalosporins and fluoroquinolones. There are concerns with rising use of tetracyclines in recent years in place of penicillins with changing pricing policies, as well as high relative use of third generation cephalosporins.

Conclusions: Multiple interventions in Azerbaijan in recent years appear to have resulted in low use of antibiotics when compared with similar countries. However, there are some concerns especially with third generation cephalosporins. There needs to be a closer look at indications to further improve antibiotic use.
LanguageEnglish
Pages77-84
Number of pages8
JournalExpert Review of Anti-infective Therapy
Volume16
Issue number1
Early online date26 Dec 2017
DOIs
Publication statusE-pub ahead of print - 26 Dec 2017

Fingerprint

Azerbaijan
Anti-Bacterial Agents
Cephalosporins
Amoxicillin-Potassium Clavulanate Combination
Tetracyclines
Fluoroquinolones
Macrolides
beta-Lactams
Pharmacists
Penicillins
Observational Studies
Retrospective Studies
Physicians

Keywords

  • antibiotic utilization
  • antibiotic resistance
  • Azerbaijan
  • policy initiatives
  • quality indicators

Cite this

@article{516b01661de9472890d6dbeafd46bc7b,
title = "Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications",
abstract = "Objectives: There have been a numerous initiatives in Azerbiajan in recent years to improve antibiotic utilization including educational programmes among patients, pharmacists and physicians. This study aimed to analyse the influence of these multiple initiatives on antibiotic utilization as a basis for suggesting future initiatives. Methods: Observational retrospective study of total antibiotic utilization from 2011 to 2015 based on import data. The quality of aggregated antibiotic prescribing was assessed against recognised indicators including those of WHO Europe, as well as compared to neighbouring countries as reference points. Results: There was a significant reduction in total antibiotic utilization from 17.1DIDs in 2011 in Azerbaijan to 8.02 DIDs in 2015, the lowest level compared with similar countries. Beta lactam antibiotics were typically the largest group of antibiotics with low overall use of co-amoxiclav (although relative utilisation rising), macrolides, cephalosporins and fluoroquinolones. There are concerns with rising use of tetracyclines in recent years in place of penicillins with changing pricing policies, as well as high relative use of third generation cephalosporins. Conclusions: Multiple interventions in Azerbaijan in recent years appear to have resulted in low use of antibiotics when compared with similar countries. However, there are some concerns especially with third generation cephalosporins. There needs to be a closer look at indications to further improve antibiotic use.",
keywords = "antibiotic utilization, antibiotic resistance, Azerbaijan, policy initiatives, quality indicators",
author = "Vafa Abilova and Amanj Kurdi and Brian Godman",
year = "2017",
month = "12",
day = "26",
doi = "10.1080/14787210.2018.1417835",
language = "English",
volume = "16",
pages = "77--84",
journal = "Expert Review of Anti-infective Therapy",
issn = "1478-7210",
number = "1",

}

Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. / Abilova, Vafa; Kurdi, Amanj; Godman, Brian.

In: Expert Review of Anti-infective Therapy, Vol. 16, No. 1, 26.12.2017, p. 77-84.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications

AU - Abilova, Vafa

AU - Kurdi, Amanj

AU - Godman, Brian

PY - 2017/12/26

Y1 - 2017/12/26

N2 - Objectives: There have been a numerous initiatives in Azerbiajan in recent years to improve antibiotic utilization including educational programmes among patients, pharmacists and physicians. This study aimed to analyse the influence of these multiple initiatives on antibiotic utilization as a basis for suggesting future initiatives. Methods: Observational retrospective study of total antibiotic utilization from 2011 to 2015 based on import data. The quality of aggregated antibiotic prescribing was assessed against recognised indicators including those of WHO Europe, as well as compared to neighbouring countries as reference points. Results: There was a significant reduction in total antibiotic utilization from 17.1DIDs in 2011 in Azerbaijan to 8.02 DIDs in 2015, the lowest level compared with similar countries. Beta lactam antibiotics were typically the largest group of antibiotics with low overall use of co-amoxiclav (although relative utilisation rising), macrolides, cephalosporins and fluoroquinolones. There are concerns with rising use of tetracyclines in recent years in place of penicillins with changing pricing policies, as well as high relative use of third generation cephalosporins. Conclusions: Multiple interventions in Azerbaijan in recent years appear to have resulted in low use of antibiotics when compared with similar countries. However, there are some concerns especially with third generation cephalosporins. There needs to be a closer look at indications to further improve antibiotic use.

AB - Objectives: There have been a numerous initiatives in Azerbiajan in recent years to improve antibiotic utilization including educational programmes among patients, pharmacists and physicians. This study aimed to analyse the influence of these multiple initiatives on antibiotic utilization as a basis for suggesting future initiatives. Methods: Observational retrospective study of total antibiotic utilization from 2011 to 2015 based on import data. The quality of aggregated antibiotic prescribing was assessed against recognised indicators including those of WHO Europe, as well as compared to neighbouring countries as reference points. Results: There was a significant reduction in total antibiotic utilization from 17.1DIDs in 2011 in Azerbaijan to 8.02 DIDs in 2015, the lowest level compared with similar countries. Beta lactam antibiotics were typically the largest group of antibiotics with low overall use of co-amoxiclav (although relative utilisation rising), macrolides, cephalosporins and fluoroquinolones. There are concerns with rising use of tetracyclines in recent years in place of penicillins with changing pricing policies, as well as high relative use of third generation cephalosporins. Conclusions: Multiple interventions in Azerbaijan in recent years appear to have resulted in low use of antibiotics when compared with similar countries. However, there are some concerns especially with third generation cephalosporins. There needs to be a closer look at indications to further improve antibiotic use.

KW - antibiotic utilization

KW - antibiotic resistance

KW - Azerbaijan

KW - policy initiatives

KW - quality indicators

UR - http://www.tandfonline.com/loi/ierz20

U2 - 10.1080/14787210.2018.1417835

DO - 10.1080/14787210.2018.1417835

M3 - Article

VL - 16

SP - 77

EP - 84

JO - Expert Review of Anti-infective Therapy

T2 - Expert Review of Anti-infective Therapy

JF - Expert Review of Anti-infective Therapy

SN - 1478-7210

IS - 1

ER -